1. Home
  2. GLUE vs TSBK Comparison

GLUE vs TSBK Comparison

Compare GLUE & TSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLUE
  • TSBK
  • Stock Information
  • Founded
  • GLUE 2019
  • TSBK 1915
  • Country
  • GLUE United States
  • TSBK United States
  • Employees
  • GLUE N/A
  • TSBK N/A
  • Industry
  • GLUE Biotechnology: Pharmaceutical Preparations
  • TSBK Banks
  • Sector
  • GLUE Health Care
  • TSBK Finance
  • Exchange
  • GLUE Nasdaq
  • TSBK Nasdaq
  • Market Cap
  • GLUE 308.8M
  • TSBK 274.5M
  • IPO Year
  • GLUE 2021
  • TSBK 1998
  • Fundamental
  • Price
  • GLUE $7.72
  • TSBK $32.23
  • Analyst Decision
  • GLUE Buy
  • TSBK
  • Analyst Count
  • GLUE 2
  • TSBK 0
  • Target Price
  • GLUE $13.50
  • TSBK N/A
  • AVG Volume (30 Days)
  • GLUE 2.5M
  • TSBK 19.1K
  • Earning Date
  • GLUE 11-06-2025
  • TSBK 10-30-2025
  • Dividend Yield
  • GLUE N/A
  • TSBK 3.21%
  • EPS Growth
  • GLUE N/A
  • TSBK 12.22
  • EPS
  • GLUE 0.29
  • TSBK 3.40
  • Revenue
  • GLUE $177,986,000.00
  • TSBK $78,338,000.00
  • Revenue This Year
  • GLUE $83.76
  • TSBK N/A
  • Revenue Next Year
  • GLUE N/A
  • TSBK N/A
  • P/E Ratio
  • GLUE $26.24
  • TSBK $9.49
  • Revenue Growth
  • GLUE 2990.57
  • TSBK 5.31
  • 52 Week Low
  • GLUE $3.50
  • TSBK $27.51
  • 52 Week High
  • GLUE $12.40
  • TSBK $38.08
  • Technical
  • Relative Strength Index (RSI)
  • GLUE 64.92
  • TSBK N/A
  • Support Level
  • GLUE $7.24
  • TSBK N/A
  • Resistance Level
  • GLUE $7.87
  • TSBK N/A
  • Average True Range (ATR)
  • GLUE 0.40
  • TSBK 0.00
  • MACD
  • GLUE 0.02
  • TSBK 0.00
  • Stochastic Oscillator
  • GLUE 75.25
  • TSBK 0.00

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

About TSBK Timberland Bancorp Inc.

Timberland Bancorp Inc is a bank holding company. It has one reportable operating segment which is defined as community banking in western Washington under the operating name Timberland Bank. The bank offers a variety of services such as checking accounts, online and mobile banking, savings accounts, home loans, consumer loans, construction loans, business rewards, cash management, small business solutions, and business checking accounts among others. It also offers loans to real estate, including residential and commercial, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.

Share on Social Networks: